We invest in companies with compelling technology and promising initial human data.

Areas of investment
Photo of someone typing on a computer

Software & data platforms

Tools for researchers, therapy developers, and clinicians.
Photo of two adults

Solutions for patients and caregivers

Innovations to help patients and caregivers manage neurological and psychiatric conditions.
Photo of computer in lab

Sensors, monitoring systems, and diagnostic technology

Software and hardware for detecting brain disorder risk, onset, progression, and response to treatment.
Photo of computer in lab

Medical devices

Medical technology that directly modulates or treats brain disorders, spanning the gamut of invasiveness and complexity.
Illustration of brain

Therapy enabling technologies

Technology used to manufacture, deliver, or otherwise enable drugs, biologics, and other therapeutics.
Photo of lab

Research tools

Laboratory instruments for scientific research and clinical workflows that enable the development and implementation of advancements in care.

How we invest

Committed to breakthrough technologies

Nexus NeuroTech Ventures, LLC is a venture capital firm based in San Francisco committed to advancing breakthrough technologies for brain disorders. We make seed and series A-C investments, and have the unique capacity to support earlier-stage programs not yet ready for formal venture capital investment through our Nexus NeuroTech Incubator Program.

Founded in 2023 by Jordi Parramon, PhD and William Marks, MD the firm brings a deep commitment to helping those with neurological and psychiatric disorders, such as Parkinson’s disease, bipolar disorder, and autism. Adjacent to these sentinel disorders are many other brain disorders that are also within scope for Nexus NeuroTech Ventures.

With the progress in understanding disease mechanisms and with advances in medical technology, we see an opportunity at this moment in time to pursue a portfolio of technology innovations aimed at addressing the spectrum of needs that patients face across their journey.

Nexus is differentiated by the partners’ operational oversight and deep domain expertise.

Connecting the dots

Nexus NeuroTech Ventures is building a portfolio that enables “connecting the dots” from a disease diagnosis and management perspective, providing a more holistic approach to brain disorders, with approaches spanning less invasive to more invasive therapeutic interventions, software- and hardware-based diagnostic technology, data platforms supporting clinical trials and clinical care, and tools directed at advancing therapy development and optimizing clinical care.  This provides a great opportunity to unlock efficiencies from a clinical and health economics perspective and from a technology perspective.

Nexus NeuroTech Ventures targets investments in companies with compelling technology and promising initial human data to enable their successful technological and business development, as well as clinical evidence generation and market access.

Grow icon

Our incubator program

Nexus NeuroTech Ventures has the ability to support highly compelling neurotechnology programs that need additional technical and/or clinical evidence development and mentorship prior to readiness for venture investment.

Want to learn more?

We welcome inquiries from company founders, academic investigators ready to commercialize their innovations, and investors who may wish to partner with us.

Contact us